| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $816K | -47.0% |
| SG&A Expense | $1.4M | -4.9% |
| Operating Income | -$2.2M | +57.4% |
| Pre-tax Income | -$2.5M | +55.9% |
| Net Income | -$2.5M | +55.9% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $239K | -62.6% |
| Total Assets | $259K | -60.9% |
| Current Liabilities | $3.0M | +226.1% |
| Total Liabilities | $3.1M | +203.9% |
| Stockholders' Equity | -$2.9M | -680.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.1M | +24.9% |
| Capital Expenditures | $966 | -96.3% |
| Investing Cash Flow | -$966 | +96.3% |
| Financing Cash Flow | $1.8M | — |
| Free Cash Flow | -$2.1M | +25.6% |